HMS Sepsis – How a State-Wide Quality Collaborative Facilitates Performance Improvements and Collaboration

The Michigan Hospital Medicine Safety Consortium (HMS) is a data-driven collaborative supported by Blue Cross and Blue Shield of Michigan. HMS provides the infrastructure needed to facilitate data collection and information sharing to support Michigan hospitals in improving the safety and quality of care for hospitalized medical patients. In 2021, HMS launched a sepsis initiative among 12 volunteer pilot hospitals. In 2022, the sepsis initiative was launched among the remaining 57 HMS hospitals. The HMS sepsis initiative assesses the care of patients meeting surveillance criteria for sepsis with the goal of improving patient experience and outcomes across the continuum of care – from early identification and management to post-discharge care coordination and 90-day outcomes. The presentation will begin with Dr. Prescott introducing participants to HMS and discussing why HMS and Blue Cross and Blue Shield of Michigan identified sepsis as a priority for Michigan hospitals. HMS data provided to participating sites will be reviewed with examples of how sites are utilizing the data, tools, and resources provided by HMS to drive quality improvement and education at their sites. Following Dr. Prescott’s presentation will be a panel session that engages HMS physicians, BCBSM leadership, a Sepsis Quality Improvement Consultant, and a physician representative from an HMS participating site.